A 3 months old male infant developed otitis media for which he was given a course of Co-trimoxazole. A few days later, he developed extensive peeling of the skin; there were no mucosal lesions and the baby was not toxic. The most likely diagnosis is:
**Core Concept**
The question is testing the understanding of a rare but serious side effect of Co-trimoxazole, which is a combination antibiotic containing sulfamethoxazole and trimethoprim. The correct answer requires knowledge of the specific dermatological manifestation associated with this medication.
**Why the Correct Answer is Right**
Co-trimoxazole can cause a severe skin reaction known as Stevens-Johnson syndrome (SJS) or toxic epidermal necrolysis (TEN). However, in this case, the baby developed extensive peeling of the skin without mucosal lesions or systemic toxicity, which is characteristic of erythema multiforme (EM). EM is a hypersensitivity reaction that typically occurs within 2-14 days after the initiation of the offending drug. The exact pathophysiology of EM is not fully understood, but it is thought to involve an immune-mediated reaction to the drug, resulting in the formation of IgG and IgM antibodies against the drug.
**Why Each Wrong Option is Incorrect**
* **Option A:** Stevens-Johnson syndrome (SJS) typically presents with mucosal lesions, which were not present in this case.
* **Option B:** Toxic epidermal necrolysis (TEN) is a more severe form of SJS, characterized by extensive skin necrosis and mucosal involvement, which is not consistent with this patient's presentation.
* **Option C:** Erythema toxicum neonatorum is a common skin condition in newborns, but it typically presents within the first few days of life and is not associated with the use of antibiotics.
**Clinical Pearl / High-Yield Fact**
Erythema multiforme can occur in response to various medications, including antibiotics, and can be a challenging diagnosis to make, especially in the absence of mucosal lesions. It is essential to consider this diagnosis in patients who develop skin peeling or rashes after starting a new medication.
**Correct Answer: D.**